MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-08-0021045
Aespire Formulations Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.42 Cr
▼ 32% YoY
Net profit · FY 2024
₹3.81 Lakh
Net margin 1.1%
EBITDA · FY 2024
₹16.15 Lakh
EBITDA margin 4.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹45 Lakh
Secured borrowings
Company age
13 yrs
Est. 2013
Employees · EPFO
5
Provident fund records
About Aespire Formulations Private Limited
Data last updated:
Aespire Formulations Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 November 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2013PTC260979. Its GSTIN is 07AAMCA2101K1ZX (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Asmira Healthcare Private Limited. It is led by directors including Anupama Sarkar and Rajat Sood.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 403 Fourth Floor Building No 49 50 Red Rose Nehru Place, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.42 Cr, a decline of 32% compared to the previous year. For the same year it recorded a net profit of ₹3.81 Lakh (net margin 1.1%) and EBITDA of ₹16.15 Lakh (EBITDA margin 4.7%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 14% over five years.
The company has about 5 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Aespire Formulations. As per MCA filings, the company has open charges of ₹45 Lakh on record. Court records list 6 cases involving the company, including 4 filed by the company and 2 filed against it; 5 cases are pending.
Aespire Formulations Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0021045). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aespireformulations.com.
Company details
CIN U74900DL2013PTC260979
Registration Number 260979
Incorporation Date 26 November 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-08-0021045
Recognitions & Rankings of Aespire Formulations
Contact details
Aespire Formulations Private Limited's registered office is in New Delhi, Delhi. Its website is aespireformulations.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address403 Fourth Floor Building No 49 50 Red Rose Nehru Place, New Delhi, Delhi, India – 110019
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Aespire Formulations Private Limited, buy the company report.
Comprehensive company report
Aespire Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Aespire Formulations operates one associated brand: Aespire Formulations. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations for anaesthesia and critical care in India. | aespireformulations.com |
Business activity
The main business activity of Aespire Formulations is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Aespire Formulations Private Limited, buy the company report.
Financials of Aespire Formulations Private Limited
FY 2025 filings availableAespire Formulations Private Limited reported revenue of ₹3.42 Cr (down 32% YoY) for FY 2024.
Revenue · FY 2024
₹3.42 Cr ▼ 32%
Net profit · FY 2024
₹3.81 Lakh margin 1.1%
EBITDA · FY 2024
₹16.15 Lakh margin 4.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 32%
3 years · compounded
▼ 14%
5 years · compounded
▼ 14%
EBITDA CAGR growth
1 year
▼ 12%
3 years · compounded
▲ 242%
5 years · compounded
▼ 10%
Revenue has declined at a compounded annual rate (CAGR) of 14% over five years, including a 32% fall in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.15 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.81 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.7% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aespire Formulations Private Limited, buy the company report.
Board of directors of Aespire Formulations Private Limited
Aespire Formulations has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anupama Sarkar | Director | 26 Nov 2013 | 12 Years 11 Months | Current |
| Rajat Sood Also directs: Aesmira Life Sciences Private Limited, Off the Grid Sporting Private Limited, Silverstone Foods Private Limited and 1 more | Director | 26 May 2016 | 10 Years 5 Months | Current |
| Suman Sood | Director | 26 Nov 2013 | 12 Years 11 Months | Current |
Auditor
Aespire Formulations Private Limited is audited by VERMA DEEPAK & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VERMA DEEPAK & CO | FY 2021 | 018849C |
Shareholding
The shareholding of Aespire Formulations Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Aespire Formulations Private Limited, buy the company report.
Charges & borrowings
Open charges
₹45 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 May 2017 | 100119133 | Hdfc Bank Limited | ₹45 Lakh | Open |
To see the full charge records of Aespire Formulations Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Aespire Formulations Private Limited has 6 court cases on record: 4 filed by Aespire Formulations, 2 filed against it. 5 cases are pending and 1 is disposed.
Total cases
6
Filed by the company
4
Filed against the company
2
Pending
5
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 1 | 4 |
| High courts | 1 | 1 | 1 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Cheque dishonour complaint | Filed by the company against Triveni Healthcare and Pharmaceuticals and Anr | Pending |
| District court, Central, Delhi | Court case (L I R) | Filed against the company by an individual | Pending |
| High Court of Delhi | Court case (RFA(COMM)) | Filed against the company by an individual | Pending |
| District court, South East, Delhi | Cheque dishonour complaint | Filed by the company against M/S Pharmaceutial and Surgical and 1 other | Pending |
| District court, South East, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of Aespire Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aespire Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aespire Formulations Private Limited has a workforce of 5 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
5
Active EPFO establishments
1
Employee growth
-37.5%
GST
Aespire Formulations has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAMCA2101K1ZX | Delhi | Active | 01 Jul 2017 |
| 09AAMCA2101K1ZT | Uttar Pradesh | Active | 30 Jul 2020 |
To see the full GST registrations and return filing status of Aespire Formulations Private Limited, buy the company report.
Recent activity
Aespire Formulations Private Limited has 4 board changes on record since 2013: 3 appointments and 1 cessation. The latest: Rajat Sood ceased to be Additional Director on 30 Sep 2016.
AGM
Aespire Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aespire Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Charges
A charge with Hdfc Bank Limited of Rs. 45.00 Lakh registered on 30 May 2017 with Charge ID 100119133 was modified on 22 Feb 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 45.00 Lakh with Charge ID 100119133 was registered on 30 May 2017.
Ceased
Rajat Sood ceased to be Additional Director.
Appointed
Rajat Sood was appointed as Director.
Appointed
Anupama Sarkar was appointed as Director.
Appointed
Suman Sood was appointed as Director.
Incorporation
26 Nov 2013
Aespire Formulations Private Limited was registered on 26 Nov 2013 with Roc Delhi I & aged 12 years 11 months as per MCA records.
Frequently asked questions
Aespire Formulations is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 November 2013 (13+ years old) and is registered under CIN U74900DL2013PTC260979.
Aespire Formulations has 3 current directors:
- Anupama Sarkar - Director
- Rajat Sood - Director
- Suman Sood - Director
The latest financial statements of Aespire Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aespire Formulations is 07AAMCA2101K1ZX, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AAMCA2101K1ZT (Uttar Pradesh).
The CIN (Corporate Identification Number) of Aespire Formulations is U74900DL2013PTC260979. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aespire Formulations has 6 court cases on record: 4 filed by the company and 2 filed against it. 5 are pending. Most are in the district courts.
Aespire Formulations was incorporated on 26 November 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
Rajat Sood ceased to be Additional Director on 30 Sep 2016. Rajat Sood was appointed as Director on 26 May 2016. Anupama Sarkar was appointed as Director on 26 Nov 2013. Aespire Formulations has 4 board changes on record in total.
Yes, Aespire Formulations is registered as a small enterprise under Udyam registration (number: UDYAM-DL-08-0021045).
Aespire Formulations can be reached through the website aespireformulations.com. Its registered office is in New Delhi, Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages